NJ Lab, Owner To Pay $13M To Settle Kickback Claims
RDx Bioscience Inc., along with its owner and embattled former CEO Eric Leykin, have agreed to pay $13.25 million to the U.S. and New Jersey to resolve government allegations that they helped...To view the full article, register now.
Already a subscriber? Click here to view full article